Bourgeon Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bourgeon Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-11,940	Closed	-$160K	–	111
2015 Q1	$160K	Sell	11,940 -5,970	-33%	-$78.3K	0.1%	103
2014 Q4	$230K	Sell	17,910 -33,193	-65%	-$380K	0.14%	94
2014 Q3	$554K	Buy	51,103 +5,612	+12%	+$64.2K	0.32%	65
2014 Q2	$584K	Sell	45,491 -4,657	-9%	-$50.6K	0.32%	68
2014 Q1	$517K	Buy	50,148 +26,507	+112%	+$298K	0.33%	69
2013 Q4	$230K	Buy	+23,641	New	+$212K	0.15%	89

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Bourgeon Capital Management's IRWD Position: Q2 2015 in Review

Bourgeon Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2015, closing a stake of 11,940 shares — an estimated $160K sold.

Bourgeon Capital Management first reported a position in IRWD in Q4 2013 and held it in 6 quarters. The position peaked at $584K in Q2 2014. 137 funds tracked by Wall St. Rank hold IRWD as of Q2 2015.

Bourgeon Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Bourgeon Capital Management sold 11,940 Ironwood Pharmaceuticals shares in Q2 2015, an estimated $160K.
Bourgeon Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 6 quarters.
Bourgeon Capital Management's Ironwood Pharmaceuticals position peaked at $584K in Q2 2014.
137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2015.

Based on Bourgeon Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.